90-Day Extension Request for ACRIVON THERAPEUTICS Trademark Opposition

Brightwake Limited filed a first 90-day request to extend the time to oppose Acrivon Therapeutics, Inc.'s trademark application for ACRIVON THERAPEUTICS. The request was filed with the TTAB on April 2, 2026 (Case TTAB99388082). This procedural filing grants Brightwake additional time to prepare and file a formal notice of opposition against the trademark registration.

Affected parties, particularly trademark applicants like Acrivon Therapeutics, should monitor the status of opposition proceedings and be prepared to respond if an opposition is ultimately filed. No immediate action is required from either party at this stage beyond watching for further filings in the TTAB case.